Sign in Subscribe
Communicable diseases

De Novo Immune Hepatitis After Liver Transplants Tied to GSTT1 Mismatch

Strategic Insights

— 1 min read

De novo immune hepatitis, a type of autoimmune hepatitis, has been linked to a genetic mismatch in liver transplant patients. Specifically, a study from Spain found that a mismatch in the glutathione S-transferase T1 (GSTT1) gene between donor and recipient increases the risk of this condition. Researchers analyzed a cohort of 110 liver transplant patients and discovered that six developed de novo immune hepatitis, all of whom had a negative GSTT1 genotype as recipients paired with a positive genotype in their donors.

Key Takeaways:

  • De novo immune hepatitis is a type of autoimmune hepatitis reported in liver transplant patients.
  • A genetic mismatch in the GSTT1 gene between donor and recipient is linked to an increased risk of de novo immune hepatitis.
  • Researchers analyzed 110 liver transplant patients and found six with de novo immune hepatitis, all with a negative GSTT1 genotype as recipients paired with a positive genotype in their donors.
  • The GSTT1 genotype combination of -/- (negative) in recipients with + (positive) in donors is associated with a statistically significant increased risk of de novo immune hepatitis (p=0.02).
  • The study's findings emphasize the importance of predictive markers in liver transplantation, such as the GSTT1 genotype combination.
  • The researchers confirmed their initial results that only the specific donor/recipient combination of GSTT1 -/- with + triggers the production of anti-GSTT1 antibodies.

Statistics:

  • 110 liver transplant patients were analyzed in the study.
  • 6 patients developed de novo immune hepatitis.
  • The GSTT1 genotype distribution among patients was: +/+ = 66, +/- = 23, -/+ = 15, -/- = 6.
  • The GSTT1 genotype combination of -/- in recipients with + in donors was associated with a statistically significant increased risk of de novo immune hepatitis (p=0.02).
  • A total of 23 patients (21%) had a GSTT1 +/- genotype.

Sources:

  • Aguilera, I., et al. "Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation." Liver Transplant, vol. 10, no. 9, 2004, pp. 1166-1172.
  • Aguilera, I., Immunology Service, Virgin of the Rocio University Hospital, Avda Manuel Siurot S-N, Seville 41013, Spain.

Read more